risperidone has been researched along with Syndrome in 40 studies
Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.
Syndrome: A characteristic symptom complex.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Six of 13 outpatients with schizophrenia who participated in a ten-week open trial of risperidone had an initial good response to the medication followed by development of intolerable affect, including feelings of agitation and depression and periods of crying and insomnia." | 9.08 | A syndrome of increased affect in response to risperidone among patients with schizophrenia. ( Ashleigh, EA; Larsen, PD, 1998) |
| "A patient with comorbid intellectual disability, catatonic schizophrenia, and recurrent oneiroid state of consciousness improved on long-acting risperidone and remains well at the three-year follow-up." | 7.81 | Effectiveness of long-acting risperidone in a patient with comorbid intellectual disability, catatonic schizophrenia, and oneiroid syndrome. ( Alessi, MC; Angeletti, G; Callovini, G; Criscuolo, S; Del Casale, A; Ferri, VR; Girardi, P; Janiri, D; Kotzalidis, GD; Massolo, AC; Rapinesi, C; Serata, D, 2015) |
| "To report a case of risperidone-induced Pisa syndrome in a patient with multiple sclerosis (MS) that resolved with lurasidone, recurred with chlorpromazine, and was complicated by possible drug-drug interactions." | 7.79 | Risperidone-induced Pisa syndrome in MS: resolution with lurasidone and recurrence with Chlorpromazine. ( Diefenderfer, LA; Iuppa, CA, 2013) |
| "Long-acting injectable (LAI) formulations of antipsychotics are valuable treatment alternatives for patients with psychotic disorders, and understanding their safe use is critical." | 5.37 | Are the long-acting intramuscular formulations of risperidone or paliperidone palmitate associated with post-injection delirium/sedation syndrome? An assessment of safety databases. ( Alphs, L; Gopal, S; Karcher, K; Kent, J; Kushner, S; Nuamah, I; Singh, J; Sliwa, JK, 2011) |
| "Six of 13 outpatients with schizophrenia who participated in a ten-week open trial of risperidone had an initial good response to the medication followed by development of intolerable affect, including feelings of agitation and depression and periods of crying and insomnia." | 5.08 | A syndrome of increased affect in response to risperidone among patients with schizophrenia. ( Ashleigh, EA; Larsen, PD, 1998) |
| "A patient with comorbid intellectual disability, catatonic schizophrenia, and recurrent oneiroid state of consciousness improved on long-acting risperidone and remains well at the three-year follow-up." | 3.81 | Effectiveness of long-acting risperidone in a patient with comorbid intellectual disability, catatonic schizophrenia, and oneiroid syndrome. ( Alessi, MC; Angeletti, G; Callovini, G; Criscuolo, S; Del Casale, A; Ferri, VR; Girardi, P; Janiri, D; Kotzalidis, GD; Massolo, AC; Rapinesi, C; Serata, D, 2015) |
| "To report a case of risperidone-induced Pisa syndrome in a patient with multiple sclerosis (MS) that resolved with lurasidone, recurred with chlorpromazine, and was complicated by possible drug-drug interactions." | 3.79 | Risperidone-induced Pisa syndrome in MS: resolution with lurasidone and recurrence with Chlorpromazine. ( Diefenderfer, LA; Iuppa, CA, 2013) |
| "Both risperidone and clozapine have been shown to be effective against negative symptoms." | 3.78 | New pharmacotherapeutic modalities for negative symptoms in psychosis. ( Lindenmayer, JP, 1995) |
| "This study evaluates the relationship between plasma homovanillic acid (pHVA) levels, which have been used to study the role of central dopamine in schizophrenia, and the positive/negative syndrome in first episode schizophrenic patients before and after antipsychotic treatment." | 3.75 | Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients. ( Baeza, I; Bernardo, M; Castro-Fornieles, J; de la Serna, E; Deulofeu, R; Goti, J; Salvà, J, 2009) |
| " A case of 'PANDAS' is presented to increase physician awareness of this disorder and to document effectiveness of risperidone in chorea and treatment-resistant disruptive behavior associated with this syndrome." | 3.70 | Risperidone in the treatment of choreiform movements and aggressiveness in a child with "PANDAS". ( Bhatara, VS; Kleinsasser, BJ; Misra, LK; Sanchez, JD, 1999) |
| "When the concepts of dementia praecox and schizophrenia were introduced by Kraepelin and Bleuler, emphasis was laid on the negative symptoms, regarded as fundamental." | 2.39 | Principal components and further possibilities with the PANSS. ( Lindström, E; von Knorring, L, 1995) |
| "Cotard syndrome was first described in 1880 by Jules Cotard as a novel subtype of anxious depression and is presently understood as a rare cluster of mood and psychotic symptoms centered on nihilistic delusions including the absence of organs and a perception of being dead." | 1.62 | Cotard Syndrome in an Adolescent With a First Episode of Psychosis. ( Boles, MK; Boyanchek, I; McGreal, AE, 2021) |
| "This short report provides guidance for antipsychotic medication dosing to improve early intervention outcomes." | 1.56 | Early behavioral and developmental interventions in ADNP-syndrome: A case report of SWI/SNF-related neurodevelopmental syndrome. ( Hopkin, R; Pedapati, E; Shillington, A; Suhrie, K, 2020) |
| "Pulmonary embolism was seen in our patient a week after starting risperidone." | 1.48 | Pseudo-Wellens' syndrome in pulmonary embolism. ( Basnyat, S; Bhattacharya, PT; Sedhai, YR, 2018) |
| "She also exhibited precocious puberty and growth hormone deficiency and required treatment for improving final height." | 1.40 | Endocrinological anomalies in a patient with 12q14 microdeletion syndrome. Completing phenotype of this exceptional short stature condition. ( Marco, FC; Nso-Roca, AP; Ricote, JM; Ruiz, MJ, 2014) |
| "Long-acting injectable (LAI) formulations of antipsychotics are valuable treatment alternatives for patients with psychotic disorders, and understanding their safe use is critical." | 1.37 | Are the long-acting intramuscular formulations of risperidone or paliperidone palmitate associated with post-injection delirium/sedation syndrome? An assessment of safety databases. ( Alphs, L; Gopal, S; Karcher, K; Kent, J; Kushner, S; Nuamah, I; Singh, J; Sliwa, JK, 2011) |
| " In the patient with laryngeal dystonia these symptoms appeared after restarting risperidone treatment, in the other patient after diminishing the dosage of risperidone and adding sertindole, and in the third patient the syndrome appeared after beginning ziprasidone." | 1.37 | Pisa syndrome and laryngeal dystonia induced by novel antipsychotics. ( Lerner, V; Miodownik, C; Witztum, E, 2011) |
| "Usher's syndrome is a genetic disorder that causes congenital sensorineural hearing loss, visual impairment due to progressive pigmentary retinopathy, and, often, vestibular dysfunction." | 1.31 | The relationship between Usher's syndrome and psychosis with Capgras syndrome. ( Medalia, A; Waldeck, T; Wyszynski, B, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (15.00) | 18.2507 |
| 2000's | 17 (42.50) | 29.6817 |
| 2010's | 14 (35.00) | 24.3611 |
| 2020's | 3 (7.50) | 2.80 |
| Authors | Studies |
|---|---|
| Shillington, A | 1 |
| Pedapati, E | 1 |
| Hopkin, R | 1 |
| Suhrie, K | 1 |
| Valadas, MTTRT | 1 |
| Bravo, LEA | 1 |
| McGreal, AE | 1 |
| Boles, MK | 1 |
| Boyanchek, I | 1 |
| Kuppili, PP | 1 |
| Gupta, R | 1 |
| Pattanayak, RD | 1 |
| Khandelwal, SK | 1 |
| Sedhai, YR | 1 |
| Basnyat, S | 1 |
| Bhattacharya, PT | 1 |
| Iuppa, CA | 1 |
| Diefenderfer, LA | 1 |
| Nso-Roca, AP | 1 |
| Marco, FC | 1 |
| Ricote, JM | 1 |
| Ruiz, MJ | 1 |
| Saddichha, S | 1 |
| Talukdar, D | 1 |
| Serata, D | 1 |
| Rapinesi, C | 1 |
| Kotzalidis, GD | 1 |
| Alessi, MC | 1 |
| Janiri, D | 1 |
| Massolo, AC | 1 |
| Ferri, VR | 1 |
| Criscuolo, S | 1 |
| Callovini, G | 1 |
| Angeletti, G | 1 |
| Girardi, P | 1 |
| Del Casale, A | 1 |
| Cordeiro, Q | 1 |
| Zung, S | 1 |
| Vallada, H | 1 |
| Lamkin, S | 1 |
| Buhl, D | 1 |
| Pasini, A | 1 |
| D'Agati, E | 1 |
| Casarelli, L | 1 |
| Curatolo, P | 1 |
| Baeza, I | 1 |
| Castro-Fornieles, J | 1 |
| Deulofeu, R | 1 |
| de la Serna, E | 1 |
| Goti, J | 1 |
| Salvà, J | 1 |
| Bernardo, M | 1 |
| Alphs, L | 1 |
| Gopal, S | 1 |
| Karcher, K | 1 |
| Kent, J | 1 |
| Sliwa, JK | 1 |
| Kushner, S | 1 |
| Nuamah, I | 1 |
| Singh, J | 1 |
| Danivas, V | 1 |
| Behere, RV | 1 |
| Varambally, S | 1 |
| Rao, NP | 1 |
| Venkatasubramanian, G | 1 |
| Gangadhar, BN | 1 |
| Chou, PH | 1 |
| Lin, BT | 1 |
| Lan, TH | 1 |
| Chan, CH | 1 |
| Schweitzer, I | 1 |
| Miodownik, C | 1 |
| Lerner, V | 1 |
| Witztum, E | 1 |
| Bonci, G | 1 |
| Varghese, E | 1 |
| Mahgoub, N | 1 |
| Zugman, A | 1 |
| Pan, PM | 1 |
| Gadelha, A | 1 |
| Mansur, RB | 1 |
| Asevedo, E | 1 |
| Cunha, GR | 1 |
| Silva, PF | 1 |
| Brietzke, E | 1 |
| Bressan, RA | 1 |
| Nakagawa, S | 1 |
| Koyama, T | 1 |
| Maeda, K | 1 |
| Shirayama, Y | 1 |
| Nukina, S | 1 |
| Yoshioka, S | 1 |
| Kawahara, R | 1 |
| Eren, I | 1 |
| Ozcankaya, R | 1 |
| Altinyazar, V | 1 |
| Mendhekar, DN | 1 |
| Kozian, R | 1 |
| Nishimura, K | 1 |
| Mikami, Y | 1 |
| Tsuchibuchi, S | 1 |
| Horikawa, N | 1 |
| Niederhofer, H | 1 |
| Kessler, H | 1 |
| Kraft, S | 1 |
| Lindenmayer, JP | 1 |
| von Knorring, L | 1 |
| Lindström, E | 1 |
| Ashleigh, EA | 1 |
| Larsen, PD | 1 |
| Schwartz, M | 1 |
| Beny, A | 1 |
| Sharf, B | 1 |
| Kleinsasser, BJ | 1 |
| Misra, LK | 1 |
| Bhatara, VS | 1 |
| Sanchez, JD | 1 |
| Kornreich, C | 1 |
| Dan, B | 1 |
| Verbanck, P | 1 |
| Pelc, I | 1 |
| Kwak, YT | 1 |
| Han, IW | 1 |
| Baik, J | 1 |
| Koo, MS | 1 |
| Blanch, J | 1 |
| Corbella, B | 1 |
| García, F | 1 |
| Parellada, E | 1 |
| Gatell, JM | 1 |
| Waldeck, T | 1 |
| Wyszynski, B | 1 |
| Medalia, A | 1 |
| Harada, K | 1 |
| Sasaki, N | 1 |
| Ikeda, H | 1 |
| Nakano, N | 1 |
| Ozawa, H | 1 |
| Saito, T | 1 |
| Jagadheesan, K | 1 |
| Nizamie, SH | 1 |
| Hillert, A | 1 |
| Maier, W | 1 |
| Wetzel, H | 1 |
| Benkert, O | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Open-label, Flexible-dose Adjunctive Bromocriptine for Patients With Schizophrenia and Impaired Glucose Tolerance[NCT03575000] | Phase 4 | 20 participants (Anticipated) | Interventional | 2023-11-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for risperidone and Syndrome
| Article | Year |
|---|---|
[Extrapyramidal syndrome].
Topics: Acute Disease; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Dibenzothiazep | 2003 |
[Neuropsychiatric symptoms in Sotos syndrome. Case report and review of the literature].
Topics: Adult; Antipsychotic Agents; Brain; Carbamazepine; Chromosome Deletion; Citalopram; Compulsive Behav | 2008 |
New pharmacotherapeutic modalities for negative symptoms in psychosis.
Topics: Affective Symptoms; Antipsychotic Agents; Clozapine; Humans; Isoxazoles; Piperidines; Psychiatric St | 1995 |
Principal components and further possibilities with the PANSS.
Topics: Affective Symptoms; Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Psychiatric Status Rating | 1995 |
2 trials available for risperidone and Syndrome
| Article | Year |
|---|---|
New pharmacotherapeutic modalities for negative symptoms in psychosis.
Topics: Affective Symptoms; Antipsychotic Agents; Clozapine; Humans; Isoxazoles; Piperidines; Psychiatric St | 1995 |
A syndrome of increased affect in response to risperidone among patients with schizophrenia.
Topics: Adult; Antipsychotic Agents; Anxiety; Disease Susceptibility; Follow-Up Studies; Humans; Male; Middl | 1998 |
35 other studies available for risperidone and Syndrome
| Article | Year |
|---|---|
Early behavioral and developmental interventions in ADNP-syndrome: A case report of SWI/SNF-related neurodevelopmental syndrome.
Topics: Antipsychotic Agents; Autism Spectrum Disorder; Behavioral Symptoms; Child, Preschool; Early Medical | 2020 |
De Clérambault's syndrome revisited: a case report of Erotomania in a male.
Topics: Aged; Aggression; Delusions; Female; Humans; Male; Middle Aged; Prognosis; Risperidone; Syndrome | 2020 |
Cotard Syndrome in an Adolescent With a First Episode of Psychosis.
Topics: Adolescent; Antipsychotic Agents; Delusions; Electroconvulsive Therapy; Female; Humans; Psychotic Di | 2021 |
Delusional denial of pregnancy: Unique presentation of Cotard's syndrome in a patient with schizophrenia.
Topics: Adult; Antipsychotic Agents; Delusions; Denial, Psychological; Female; Humans; Pregnancy; Pregnancy | 2017 |
Pseudo-Wellens' syndrome in pulmonary embolism.
Topics: Antipsychotic Agents; Chest Pain; Coronary Stenosis; Electrocardiography; Humans; Male; Pulmonary Em | 2018 |
Risperidone-induced Pisa syndrome in MS: resolution with lurasidone and recurrence with Chlorpromazine.
Topics: Adult; Antipsychotic Agents; Child Development Disorders, Pervasive; Chlorpromazine; Gait Ataxia; Hu | 2013 |
Endocrinological anomalies in a patient with 12q14 microdeletion syndrome. Completing phenotype of this exceptional short stature condition.
Topics: Antipsychotic Agents; Body Height; Child; Child Behavior Disorders; Chromosome Deletion; Dwarfism; E | 2014 |
Serpentine tongue syndrome associated with risperidone long-acting injection treatment.
Topics: Antipsychotic Agents; Humans; Male; Middle Aged; Movement Disorders; Risperidone; Syndrome; Tongue | 2014 |
Effectiveness of long-acting risperidone in a patient with comorbid intellectual disability, catatonic schizophrenia, and oneiroid syndrome.
Topics: Adult; Ambroxol; Antipsychotic Agents; Brain; Dreams; Follow-Up Studies; Humans; Intellectual Disabi | 2015 |
Pisa syndrome induced by rapid increase and high dosage of risperidone.
Topics: Adolescent; Antipsychotic Agents; Dystonia; Humans; Male; Risperidone; Schizophrenia; Syndrome | 2008 |
Extrapyramidal side effects: could you identify them in the emergency department?
Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Dopamine Antagonists; Dyskinesi | 2009 |
Dose-dependent effect of risperidone treatment in a case of 22q13.3 deletion syndrome.
Topics: Abnormalities, Multiple; Adolescent; Aggression; Animals; Antipsychotic Agents; Chromosome Deletion; | 2010 |
Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Dopamine; Female; Follow-Up Studies; Homovanillic Acid; Humans; Male; P | 2009 |
Are the long-acting intramuscular formulations of risperidone or paliperidone palmitate associated with post-injection delirium/sedation syndrome? An assessment of safety databases.
Topics: Chemistry, Pharmaceutical; Clinical Trials as Topic; Conscious Sedation; Databases, Factual; Delayed | 2011 |
Electroconvulsive therapy in the treatment of delirious mania: a report of 2 patients.
Topics: Adolescent; Antimanic Agents; Bipolar Disorder; Catatonia; Delirium; Electroconvulsive Therapy; Fema | 2010 |
Chronic Cotard's syndrome: recovery from 2 years' bed-ridden status.
Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Chronic Disease; Delusions; Drug The | 2011 |
Anticonvulsant hypersensitivity syndrome: a rare and serious complication.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Anticonvulsants; Antipsychotic Agents; Bipolar Di | 2011 |
Pisa syndrome and laryngeal dystonia induced by novel antipsychotics.
Topics: Adult; Antipsychotic Agents; Dystonia; Humans; Imidazoles; Indoles; Laryngeal Diseases; Male; Middle | 2011 |
A case of Diogenes syndrome: clinical and ethical challenges.
Topics: Aged, 80 and over; Antihypertensive Agents; Antipsychotic Agents; Diagnosis, Differential; Female; G | 2012 |
Brain tumor in a patient with attenuated psychosis syndrome.
Topics: Adolescent; Antipsychotic Agents; Brain Neoplasms; Cognitive Behavioral Therapy; Combined Modality T | 2013 |
Charles Bonnet syndrome with visual hallucinations of childhood experience: successful treatment of 1 patient with risperidone.
Topics: Antipsychotic Agents; Cataract Extraction; Child; Diabetic Retinopathy; Female; Hallucinations; Huma | 2003 |
Risperidone-induced rabbit syndrome in mood disorder.
Topics: Antipsychotic Agents; Depressive Disorder, Major; Diagnosis, Differential; Hallucinations; Humans; M | 2004 |
Rabbit syndrome induced by combined lithium and risperidone.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Drug Therapy, Combination; Dy | 2005 |
[Brief case report. Duloxetine in Cotard syndrome].
Topics: Affective Disorders, Psychotic; Aged; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; | 2005 |
Pisa syndrome resolved after switching to olanzapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Diagnostic and Statistical Manual of Mental Disorders; | 2007 |
Efficacy of risperidone treatment in Smith-Magenis syndrome (del 17 pll. 2).
Topics: Abnormalities, Multiple; Adolescent; Aggression; Antipsychotic Agents; Attention Deficit Disorder wi | 2007 |
Risperidone-induced rabbit syndrome.
Topics: Aged; Antipsychotic Agents; Basal Ganglia Diseases; Female; Humans; Mouth Diseases; Risperidone; Syn | 1998 |
Risperidone in the treatment of choreiform movements and aggressiveness in a child with "PANDAS".
Topics: Aggression; Antipsychotic Agents; Autoimmune Diseases; Child; Child Behavior Disorders; Chorea; Huma | 1999 |
Treating Charles Bonnet syndrome: understanding inconsistency.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Hallucinations; Haloperidol; Humans; Male; Psychotic | 2000 |
Relation between cholinesterase inhibitor and Pisa syndrome.
Topics: Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Donepezil; Dopamine Antagonists; Dys | 2000 |
Manic syndrome associated with efavirenz overdose.
Topics: Adult; Alkynes; Anti-HIV Agents; Antipsychotic Agents; Benzoxazines; Bipolar Disorder; Cyclopropanes | 2001 |
The relationship between Usher's syndrome and psychosis with Capgras syndrome.
Topics: Aged; Antipsychotic Agents; Capgras Syndrome; Diagnosis, Differential; Female; Hearing Loss, Sensori | 2001 |
Risperidone-induced Pisa syndrome.
Topics: Adult; Antipsychotic Agents; Dystonia; Humans; Male; Risperidone; Schizophrenia; Syndrome | 2002 |
Risperidone-induced Pisa syndrome.
Topics: Adult; Antipsychotic Agents; Dystonic Disorders; Female; Humans; Intellectual Disability; Posture; P | 2002 |
Risperidone in the treatment of disorders with a combined psychotic and depressive syndrome--a functional approach.
Topics: Adult; Aged; Antipsychotic Agents; Depressive Disorder; Female; Humans; Isoxazoles; Male; Middle Age | 1992 |